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Conclusion Preemptive use of gabapentin is a safe and 
effective way to reduce postoperative pain and morphine 
consumption in parturients after cesarean surgery.
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Introduction
Although the rate of cesarean delivery is increasing but 
pain after delivery is a major concern and there are many 
attempts to reduce pain after cesarean delivery without total 
success [1–3]. Postoperative pain after cesarean can disturb 
care and breast feeding of the mother [3]. Opioid used for 
a long time to reduce postoperative pain but it is not with-
out side effect especially when used intrathecally [4–6].
the four classic side effects of opioid are pruritus, nausea 
and vomiting, urinary retention and respiratory depression 
[4–6]. Most side effects are dose dependent and may be 
more common if opioids were used intrathecally [5, 6]. the 
preoperative use of gabapentin has been shown to decrease 
postoperative pain after many surgical procedures [7, 8]. 
One study in epileptic parturient showed that the rates of 
maternal complication, cesarean section, miscarriage, low 
birth weight and malformation are similar to those seen in 
the general population and found its use safe in pregnancy 
and breast feeding period [9, 10]. chronic pain is a compli-
cation of untreatment or under treatment of acute pain [11]. 
Kainu et al. [11] confirmed that 6 month after cesarean 
delivery, some patients experience pain that affects baby 
care. It confirmed that gabapentin exposure during preg-
nancy did not lead to an increased risk for adverse maternal 
and fetal events [11]. the primary aim of our study was to 
investigate efficacy of 300 mg of oral gabapentin and 10 μg 
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Purpose Pain after cesarean delivery is a leading cause 
of chronic pain and there are many attempts to reduce it 
without total success. Gabapentin is effective in reducing 
acute and chronic pain with little experience in parturient. 
the purpose of this study is to compare the effect of pre-
emptive gabapentin with intrathecal fentanyl on reducing 
postoperative pain and morphine consumption in cesarean 
surgery.
Methods Seventy-eight primiparous women who sched-
uled for non-emergency cesarean delivery were enrolled in 
the study and separated into two groups. the control group 
received 12.5 mg of heavy bupivacaine 0.5 % plus 10 μg of 
fentanyl intrathecally and the case group received 300 mg 
of gabapentin orally 2 h before surgery and 12.5 mg of 
heavy bupivacaine 0.5 % intrathecally. Data collection 
including blood pressure, heart rate, neonate sedation, 
Apgar score, visual analogous scale at several hours, at 
first, need to analgesic postoperatively.
Results In the fentanyl group, the need for analgesic drug 
was earlier, total dose of morphine in 24 h and patient sat-
isfaction was higher than the gabapentin group. the mean 
visual analogous scale at several hours postoperatively in 
the fentanyl groups was significantly higher than the gabap-
entin groups (P = 0.001).
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of intrathecal fentanyl on postoperative pain. Secondary 
aim consists of patients’ satisfaction.
Methods
this randomized double-blinded clinical trial was con-
ducted between May 2012 and September 2012 in our edu-
cational hospitals and was approved by the ethics commit-
tee of our university and is registered at the clinicaltrials.
gov database (reference no. Irct201202241936n8). this 
study was performed according to the requirements of the 
declaration of Helsinki. After attaining informed consent 78 
full term primiparous women (ASA physical status I or II) 
scheduled for elective cesarean delivery under spinal anes-
thesia were enrolled in this study. Parturients with contrain-
dications to neuraxial anesthesia or to any study medication, 
smoking, hepatitis, chronic use of gabapentin or opioid, 
patients with psychological problem, severe preeclampsia, 
parturients with known fetus abnormality and patients with 
diabetic mellitus were excluded. After obtaining writing 
informed consent, the patients were randomly divided with 
a computerized random number generator. Gabapentin cap-
sule and lactose capsule in the same color were given to par-
turients of the gabapentin and control group by nurse staff, 
that is not involved in study, 2 h before surgery. Maternal 
demographic data including weight, age, body mass index 
(BMI) and gravidity was recorded. Before the spinal anes-
thesia was performed, the patients were placed under stand-
ard monitoring and received IV lactated ringer’s solution 
8 ml/kg. Oxygen was provided during anesthesia, and the 
patients were covered with drapes but not actively warmed. 
the patients were divided equally into two groups (n = 39, 
each). the control group received intrathecal 0.5 % heavy 
bupivacaine 12.5 mg plus 10 μg of fentanyl (Arzneimittel 
Vertriebs-GmbH, Austria). the case group received 300 mg 
gabapentin (Gaptine 300 mg capsule; Pfizer, Goedecke 
GmbH, Germany) orally, 2 h before surgery and intrathecal 
0.5 % heavy bupivacaine 12.5 mg. case and control groups 
received spinal anesthesia in a sitting position at the l4–l5 
interspace with a midline approach, using a 25-gauge nee-
dle (KIMBerlY-clArK* Quincke Point Spinal needle). 
Solutions were prepared by a second anesthesiologist so 
that the anesthesiologist performing the spinal block was 
blinded to the drug that was injected. the patients were 
placed in a supine position with left uterine displacement. 
Hypotension was defined as a decrease in systolic blood 
pressure to < 90 mmHg or 20 % less than baseline value. 
It was treated with 5–10 mg of ephedrine IV and bradycar-
dia (heart rate < 50) was treated with intravenous atropine 
0.5 mg. nausea, sedation and pruritus were assessed on 
modified four-point ordinal scales (0 = absent, 1 = mild, 
2 = moderate, 3 = severe) [12]. the degree of sedation was 
assessed in five-point scale: 1 = fully awake and oriented, 
2 = drowsy, 3 = eyes closed but rousable to command, 
4 = eyes closed but rousable to mild physical stimulation, 
5 = eyes closed but unarousable to mild physical stimula-
tion [13]. Sedation grades 3 and 4 were considered as deep 
sedation. nausea treatment by metoclopramide 10 mg IV 
and pruritus was treated with slow infusion of diphenhy-
dramine 25 mg as needed. After delivery of the neonate and 
clamping of umbilical cord IV syntocinon 15 U diluted in 
1 l ringer’s lactate solution was infused till end of surgery. 
neonatal demographic data including gestational age, birth 
weight, Apgar score at 1 and 5 min, neonate intensive care 
unit admission were recorded. An attending anesthesiologist 
assessed neonate Apgar score at 1 and 5 min after delivery 
and neonate was assessed by pediatrician attending if Apgar 
score was low (Apgar score lower than 7 within 5 min of 
the baby being born) [14]. According to our hospital prac-
tice all patients in control and case group received clinda-
mycin 600 mg IV and diclofenac 100 mg rectally at the end 
of surgery. A urinary catheter was left in situ to be removed 
24 h after surgery and patents transferred to recovery room 
till 1 h postoperatively. the pain treatment regimen was 
consisting of IV morphine 1 mg on demand of the patients 
with an interval of 5 min up to 10 mg in the first 24 h. 
Breakthrough pain was treated upon patient request with 
diclofenac 100 mg rectally and 2 mg morphine subcutane-
ously every 6 h. no other medication was given to patients 
in first day after surgery. After this time injection of mor-
phine could be substituted with acetaminophen 1 g orally 
and diclofenac 100 mg rectally every 8 h on demand of the 
patients. Patients were assessed in recovery room and 2, 4, 
6, 12, 24 h after surgery. In accordance with Dahlgren, a 
100-mm visual analog scale (VAS) (0 = no pain,100 = the 
worst imaginable pain) was used postoperatively to assess 
pain on rest and after coughing [15]. Satisfaction with pain 
management was assessed by numerical rating scale (nrS) 
from 0 to 10 (0 = not satisfied, 10 = completely satis-
fied) [14]. Any difficulty in breast feeding of the ward was 
recorded.
Data were analyzed using the Statistical Package for the 
Social Sciences (SPSS for Windows, version 17.0, SPSS Inc, 
and chicago, Il, USA). Descriptive statistics (e.g., mean and 
median) were used to assess the distribution of data for each 
variable. the Mann–Whitney test and chi-square test were 
used to compare differences between groups. P values of 
0.05 or less were considered to be significant.
Results
there were no significant differences between the groups 
in terms of demographic or surgical data (table 1). the 
amount of bleeding, pulse rate, oxygen saturation, time of 
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surgery, neonatal Apgar in minutes 1 and 5, shivering and 
vomiting were equal in two groups of participants after 
each time interval (table 1).
We lost one patient in the gabapentin group due to fail-
ure of the spinal block. there was no need for rescue doses 
of fentanyl during the surgery in either group. there were 
no signs of bradycardia or respiratory depression in either 
of the groups. none of the patients suffered from postspi-
nal headache or other neurologic complications. no sign of 
respiratory depression was seen in neonate in the gabapen-
tin and fentanyl group.
the need for analgesic drug in the fentanyl group was 
earlier than the gabapentin group and total dose of mor-
phine in 24 h was higher in the fentanyl group (table 2).
the median (range) of maternal sedation score in gabap-
entin was higher than fentanyl groups [0.00(0–1) and 
0.00(0–0), respectively] (P = 0.012).
the mean (95 % confidence interval) VAS scores were 
24 mm (13–30) and 38 mm (24–56) in the gabapentin and 
fentanyl groups, respectively (P = 0.001) (Fig. 1).
Patient satisfaction was higher in the gabapentin group 
relative to the fentanyl group (table 2).
Table 1  Maternal demographics
a




 Body mass index
Gabapentin group (n = 38)a Fentanyl group (n = 39) P value
Age (years)b 27 (4) 28 (4) 0.731
Weight (kg)b 78 (14) 79 (13) 0.455
BMI Scoreb,c (kg/m2) 29 (3) 28 (3) 0.453
Gestational age (weeks)b 37.3 (1.3) 37.5 (1.1) 0.476
Duration of surgery (min)b 34 (10) 34 (9) 0.900
Table 2  Maternal 
hemodynamic data
a
 Systolic blood pressure
b




  Mean (SD)
e
 Median (range)
Gabapentin group (n = 38) Fentanyl group (n = 39) P value
SBPa (mmHg)d
 Pre-induction 116.13 (10.72) 111.00 (9.63) 0.439
 During cesarean section 114.58 (13.21) 109.54 (18.41) 0.172
 In recovery room 101.77 (13.02) 104.42 (10.70) 0.333
DBPb (mmHg)d
 Pre-induction 64.50 (13.85) 65.38 (12.10) 0.766
 During cesarean section 71.23 (13.91) 75.42 (10.73) 0.145
 In recovery room 62.13 (12.80) 57.38 (13.37) 0.116
Prc (/min)d
 Pre-induction 94.33 (16.79) 88.30 (17.36) 0.125
 During cesarean section 86.92 (12.35) 85.13 (12.46) 0.528
 In recovery room 87.50 (16.22) 86.74 (15.57) 0.835
O2 saturationd 98.76 (1.07) 98.85 (0.93) 0.718
Vomiting (%) 4 (10.26) 5 (12.82) 0.937
Shivering (%) 9 (23.08) 7 (17.95) 0.808
Pruritus (%) 0 (0.0) 0 (0.0) 1.000
Apgare
 Min 1 10 (7–10) 10 (7–10) 0.404
 Min 5 10 (9–10) 10 (9–10) 0.979
Onset of 1st analgesic (h)d 4.59 (1.63) 2.65 (0.92) 0.000
total dosage of analgesic (mg)d 7.18 (3.26) 12.62 (5.16) 0.000
Mother sedation (%) 0.012
 Score: 1 32 (84.2) 39 (100.0)
 Score: 2 6 (15.8) 0 (0.0)
Patient satisfactione 7 (4–10) 5 (1–9) 0.0001
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Discussion
the results of our study suggest that a 300 mg single dose 
of gabapentin given orally 2 h before cesarean delivery 
can improve significantly pain scores in the first 48 h post-
partum, reduce onset of first need and total dose of mor-
phine consumption to relieve postpartum pain and increase 
patient satisfaction without any hemodynamic change in 
comparison to routine use of intrathecal opioid.
Unfortunately there are no clinical trails that compare 
the effect of intrathecal opioid and gabapentin on postoper-
ative pain and there is only a few clinical trails on the effect 
of pre-emptive gabapentin on postoperative pain in partu-
rient. Moore et al. [16] studied forty-six women undergo-
ing cesarean delivery to receive preoperative gabapentin 
600 mg, or placebo. Spinal anesthesia was achieved with 
0.75 % hyperbaric bupivacaine 12 mg, fentanyl 10 μg and 
morphine 100 μg. Postoperative analgesia was initiated 
with intraoperative ketorolac and acetaminophen, and con-
tinued with postoperative diclofenac, acetaminophen and 
morphine. they assessed patients at 6, 12, 24 and 48 h after 
spinal anesthesia for pain at rest and on movement using 
a VAS, satisfaction, opioid consumption and side effects. 
they also assessed neonatal interventions, Apgar scores, 
umbilical artery blood gases and breastfeeding difficulties. 
chronic pain was assessed 3 months after delivery. Mater-
nal and umbilical vein gabapentin plasma concentrations 
were measured in a subgroup of patients. they resulted that 
pain scores on movement at 24 h were 21 mm in the gabap-
entin and 41 mm in the placebo group (P = 0.001) and 
maternal satisfaction was higher in the gabapentin group. 
there found no difference in opioid consumption between 
two groups. Severe maternal sedation was more common 
in the gabapentin group. there was no difference in neona-
tal Apgar scores, interventions or umbilical artery pH. the 
incidence of pain at 3 months was similar in both groups. 
they concluded that preoperative gabapentin 600 mg in 
the setting of multimodal analgesia reduces post-cesarean 
delivery pain and increases maternal satisfaction in com-
parison with placebo. there is some deference between 
our study and study of Moore and colleague. We did not 
inject intrathecal morphine because synergism effects of 
intrathecal morphine with gabapentin in cnS can enhance 
analgesia [8] and it could change our results. Sedation can 
influence perception of pain and is dependent to the dose 
of gabapentin; to avoid effect of sedation on pain score we 
used 300 mg of gabapentin. All the findings of this study 
confirm us. In present study we tried to avoid synergism 
effect on gabapentin on sedation score in case group by 
decreasing dose of gabapentin.
Ajori et al. [17] investigated effects of pre-emptive use 
of gabapentin on postoperative pain, nausea and vomiting 
and meperidine consumption in patients after hysterectomy 
by a double-blind randomized clinical trial. 140 patients 
were randomly assigned to one of two groups according to 
the method of treatment, gabapentin or placebo. Pain was 
assessed on a visual analogue scale (VAS) at 1, 4, 8, 12 and 
24 h at rest. Patients in the gabapentin group had signifi-
cantly lower VAS scores at all time intervals than those in 
the placebo group. the total meperidine consumed in the 
gabapentin group was significantly less than in the placebo 
group. Postoperative nausea and vomiting (POnV) and 
antiemetic drug consumption were significantly decreased 
in gabapentin group. they concluded that pre-emptive use 
of gabapentin 600 mg orally, significantly decreases post-
operative pain and POnV, and also rescues analgesic and 
antiemetic drug requirements in patients who undergo 
abdominal hysterectomy. Some findings of this study 
confirm us (pain score and opioid consumption) and oth-
ers (incidence of postoperative nausea and vomiting and 
antiemetic drug consumption) are against us.
rorarius et al. [7] tested effect of gabapentin on preven-
tion of acute nociceptive and inflammatory pain in animals 
and volunteers, especially when given before trauma. they 
gave 1,200 mg of gabapentin or 15 mg of oxazepam (active 
placebo) 2.5 h prior to induction of anesthesia to patients 
undergoing elective vaginal hysterectomy in an active pla-
cebo-controlled, double-blind, randomized study. Gabapen-
tin reduced the need for additional postoperative pain treat-
ment (PcA boluses of 50 μg of fentanyl) by 40 % during 
the first 20 postoperative hours. they concluded that visual 
analogous pain score (VAS) during the first 2 h postopera-
tive at rest and activation were significantly higher in the 
active placebo group compared to the gabapentin-treated 
patients. In addition, pretreatment with gabapentin reduced 
the degree of postoperative nausea and incidence of vom-
iting/retching possibly either due to the diminished need 
for postoperative pain treatment with opioids or because 
of an antiemetic effect of gabapentin itself. the findings of 
this study explain and confirm lower pain score at rest and 
Fig. 1  Visual analog scale (VAS) scores at several hours post-surgery
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coughing and reduce analgesic consumption in gabapentin 
group in our study, but incidence of vomiting/retching did 
not differ between case and control in our study.
Dirks et al. [18] investigated 70 patients undergoing 
radical mastectomy to determine effect of gabapentin on 
morphine consumption and postoperative pain in a ran-
domized, double-blind study. All patients in case group 
received a single dose of oral gabapentin (1,200 mg) and 
control group received placebo 1 h before surgery. Patients 
received patient-controlled analgesia with morphine at 
doses of 2.5 mg with a lock-out time of 10 min for 4 h post-
operatively. Pain was assessed on a VAS at rest and during 
movement, and side effects were assessed on a four-point 
verbal scale 2 and 4 h postoperatively. they found gabap-
entin reduced total morphine consumption (P < 0.0001). 
Pain during movement was reduced from 41 to 22 mm at 
2 h postoperatively (P < 0.0001) and from 31 to 9 mm at 
4 h postoperatively (P = 0.018). no significant differences 
between groups were observed with regard to pain at rest or 
side effects. they concluded that a single dose of 1,200 mg 
oral gabapentin resulted in a substantial reduction in post-
operative morphine consumption and movement-related 
pain after radical mastectomy, without significant side 
effects. All finding of this study confirm us, except pain at 
rest.
Short et al. [19] studied effects of 300 or 600 mg oral 
gabapentin, or placebo on postoperative pain after deliv-
ery. One hundred thirty-two women were randomized in 
this study. Pain assessments at rest and on movement (VAS 
0–100 mm) were recorded at 6, 12, 24 and 48 h after surgi-
cal incision. Pain on movement at 24 h, patient satisfaction 
with analgesia, supplemental opioid consumption, lactation 
difficulties, neonatal outcomes, maternal sedation and other 
adverse effects were recorded. result showed no obvious 
difference between groups. they concluded that a single 
preoperative dose of gabapentin (300 and 600 mg) did not 
improve post-cesarean analgesia compared to placebo in 
the context of a multimodal analgesic regimen and a larger 
study is required. the findings of this study are against us.
We had one limitation in our study. It wasn’t possible for 
us to measure maternal and umbilical gabapentin level to 
find best time of its administration and appropriate dose of 
gabapentin with less effect on neonate and most effect on 
pain perception in parturient. the best way to explain the 
finding of this study is to check correlation between blood 
gabapentin levels with parturient pain scores and neonate 
status.
Conclusion
Pre-emptive use of gabapentin is a safe way to reduce post-
operative pain and morphine consumption in parturient 
after cesarean surgery and can be a substitute for intrathe-
cal opioid especially in patients who are sensitive to side 
effect of opioids.
Conflict of interest not declared.
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